WallStSmart

Agilent Technologies Inc (A)vsOpko Health Inc (OPK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Agilent Technologies Inc generates 1064% more annual revenue ($7.07B vs $606.88M). A leads profitability with a 18.3% profit margin vs -37.2%. A appears more attractively valued with a PEG of 1.19. A earns a higher WallStSmart Score of 61/100 (C+).

A

Buy

61

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 7.3Quality: 5.3
Piotroski: 3/9Altman Z: 1.99

OPK

Avoid

31

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASignificantly Overvalued (-318.5%)

Margin of Safety

-318.5%

Fair Value

$30.80

Current Price

$112.98

$82.18 premium

UndervaluedFair: $30.80Overvalued

Intrinsic value data unavailable for OPK.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

A2 strengths · Avg: 8.5/10
Return on EquityProfitability
20.0%9/10

Every $100 of equity generates 20 in profit

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

OPK1 strengths · Avg: 10.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Areas to Watch

A3 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-3.6%2/10

Earnings declined 3.6%

OPK4 concerns · Avg: 2.3/10
Market CapQuality
$859.83M3/10

Smaller company, higher risk/reward

PEG RatioValuation
93.652/10

Expensive relative to growth rate

Return on EquityProfitability
-17.1%2/10

ROE of -17.1% — below average capital efficiency

Revenue GrowthGrowth
-19.2%2/10

Revenue declined 19.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : A

The strongest argument for A centers on Return on Equity, Operating Margin. Profitability is solid with margins at 18.3% and operating margin at 22.9%. PEG of 1.19 suggests the stock is reasonably priced for its growth.

Bull Case : OPK

The strongest argument for OPK centers on Price/Book.

Bear Case : A

The primary concerns for A are Altman Z-Score, Piotroski F-Score, EPS Growth.

Bear Case : OPK

The primary concerns for OPK are Market Cap, PEG Ratio, Return on Equity.

Key Dynamics to Monitor

A profiles as a mature stock while OPK is a turnaround play — different risk/reward profiles.

OPK carries more volatility with a beta of 1.52 — expect wider price swings.

A is growing revenue faster at 7.0% — sustainability is the question.

A generates stronger free cash flow (175M), providing more financial flexibility.

Bottom Line

A scores higher overall (61/100 vs 31/100), backed by strong 18.3% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Agilent Technologies Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.

Opko Health Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.

Want to dig deeper into these stocks?